NCT01950923View on ClinicalTrials.gov

Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Kidney Tumor
Interventions
DRUG

sildenafil citrate

Given PO

OTHER

placebo

Given PO

PROCEDURE

therapeutic conventional surgery

Undergo standard robotic partial nephrectomy

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01950923 - Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer | Biotech Hunter | Biotech Hunter